Lisinopril And Hydrochlorothiazide
Product Images NDC 71335-0060

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 71335-0060). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Of Lisinopril (Image 1)

Chemical structure diagram of Lisinopril and Hydrochlorothiazide showing the molecular arrangement with atoms and bonds, including water of hydration indicated as ·2H2O.*

FDA Label Image

Structural Formula Of Hydrochlorothiazide (Image 2)

Chemical structure diagram depicting the molecular structure of the active ingredient, likely representing one component of Lisinopril and Hydrochlorothiazide, showing a benzene ring with attached chlorine, sulfonamide, and heterocyclic groups.*

FDA Label Image

Label Image (Lbl713350060)

Label for Lisinopril and Hydrochlorothiazide 10/12.5 mg tablets by Bryant Ranch Prepack. The label compares it to Zestoretic 10/12.5 mg tablets by Watson Pharma Private Limited. It includes storage instructions (20°-25°C), a barcode, lot number 1523487, and an NDC number 71335-006-01. The tablet is identified as pink and round.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.